1/27
09:11 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/27
09:11 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/27
08:08 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
1/22
08:51 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/21
09:25 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/21
09:25 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/21
07:17 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/21
07:17 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/20
09:10 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/20
09:10 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/20
08:11 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/20
08:11 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/13
08:32 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/13
08:32 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
1/9
09:14 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.
Medium
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.
1/9
09:14 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.
Medium
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.
12/9
08:11 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
11/20
06:02 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/20
06:02 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
11:43 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/18
11:43 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/18
09:00 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/18
09:00 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/17
04:15 pm
rvmd
Revolution Medicines initiated with an Outperform at Wolfe Research
Low
Report
Revolution Medicines initiated with an Outperform at Wolfe Research
11/17
04:15 pm
rvmd
Revolution Medicines initiated with an Outperform at Wolfe Research
Low
Report
Revolution Medicines initiated with an Outperform at Wolfe Research